Key result
Novel TPM1 D219V mutation increases Ca2+ sensitivity and impairs relaxation, supporting pathogenicity in HCM.
Why the study?
A new de novo TPM1 variant (p.D219V) was identified in a young sudden cardiac death victim with post-mortem-diagnosed HCM, prompting investigation of its structural and functional properties.
The de novo D219V mutation in cardiac tropomyosin increases calcium sensitivity and impairs relaxation at low calcium concentrations, providing a molecular mechanism for its pathogenicity in hypertrophic cardiomyopathy.
May aid HCM variant interpretation; hypothesis-generating from animal data and should not yet change practice.
Hypertrophic cardiomyopathy (HCM), caused by mutations in thin filament proteins, manifests as moderate cardiac hypertrophy and is associated with sudden cardiac death (SCD). We identified a new de novo variant, c.656A>T (p.D219V), in the TPM1 gene encoding cardiac tropomyosin 1.1 (Tpm) in a young SCD victim with post-mortem-diagnosed HCM. We produced recombinant D219V Tpm1.1 and studied its structural and functional properties using various biochemical and biophysical methods. The D219V mutation did not affect the Tpm affinity for F-actin but increased the thermal stability of the Tpm molecule and Tpm-F-actin complex. The D219V mutation significantly increased the Ca2+ sensitivity of the sliding velocity of thin filaments over cardiac myosin in an in vitro motility assay and impaired the inhibition of the filament sliding at low Ca2+ concentration. The molecular dynamics (MD) simulation provided insight into a possible molecular mechanism of the effect of the mutation that is most likely a cause of the weakening of the Tpm interaction with actin in the "closed" state and so makes it an easier transition to the “open” state. The changes in the Ca2+ regulation of the actin-myosin interaction characteristic of genetic HCM suggest that the mutation is likely pathogenic.
No takes yet. Share an insight, caveat, or question.
Tsaturyan et al. (2022) studied Hypertrophic cardiomyopathy (n=1). TPM1 c.656A>T (p.D219V) mutation vs. Wild-type TPM1 was evaluated on In vitro structural and functional properties of Tpm (Ca2+ sensitivity and thermal stability). The de novo D219V mutation in the TPM1 gene significantly increased Ca2+ sensitivity and impaired relaxation at low Ca2+ concentrations in vitro, indicating it is likely pathogenic for hypertrophic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: